China Releases New Standards on Registration of Drug Substances Containing Mixed Powder

Posted 12 January 2012 | By Alexander Gaffney, RAC 

China's State Food and Drug Administration (SFDA) today released new standards on the registration of drug substances containing mixed powders.

The new notice is intended to standardize and clarify relevant requirements of "drug substances mixed powder" used in the preparation of pharmaceutical products.

SFDA noted that this new standard should promote a higher level of product quality amongst products containing the mixed powders.

Regulatory Focus newsletters

All the biggest regulatory news and happenings.